Stada Explores €6B Cooper Consumer Health Buy from CVC Consortium
CVC's consortium is the seller of Cooper Consumer Health. A ~€6 billion sale would provide a significant exit, likely above the investment's carrying value, generating returns for CVC shareholders. The deal underscores CVC's ability to create value in healthcare assets.
- ▲ CVC consortium to exit Cooper Consumer Health at ~€6 billion
- ▲ Strong investor demand for healthcare assets
- ▼ Deal collapse could weigh on CVC shares
- ▼ Market downturn or competing offers might reduce valuation
▼ Show FAQ (3) ▲ Hide FAQ
What stake does CVC hold in Cooper?
CVC Capital Partners acquired a majority stake in Cooper Consumer Health in 2019 through its funds, though the exact percentage has not been disclosed.
How much return could CVC realize?
Assuming a €6 billion enterprise value, the return depends on initial investment and follow-on capital, but it likely represents a significant multiple of invested capital.
What other assets does CVC own in healthcare?
CVC has invested in several healthcare companies, including European hospital chains and pharma services, but Cooper is one of its larger consumer health holdings.